Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rajesh R. Singh
Observed names:
R Singh,
Raghvendra Singh,
Rajesh R Singh,
Rajesh Singh
Institution:
Maulana Azad Medical College
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Maulana Azad Medical College,
Institut für Hämatopathologie Hamburg
ORCID:
0000-0001-9082-0982
Observed ORCID:
0000-0001-9082-0982
OpenAlex ID:
A5103195876
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow
2013
·
Khaled Alayed
, Keyur P. Patel
, et al.
·
American Journal of Hematology
·
149
PDF
Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma
2013
·
Yi Zhou
, Xiangshan Fan
, et al.
·
Modern Pathology
·
45
Detection of High-Frequency and Novel DNMT3A Mutations in Acute Myeloid Leukemia by High-Resolution Melting Curve Analysis
2012
·
Rajesh R. Singh
, Ashish Bains
, et al.
·
Journal of Molecular Diagnostics
·
35
PDF
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy
2015
·
Rajesh R Singh
, Paari Murugan
, et al.
·
Modern Pathology
·
29
PDF
MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer
2018
·
Lianghua Fang
, Hui Chen
, et al.
·
Oncotarget
·
19
PDF
Endleukemia Assay v1: Enabling NGS-Based Comprehensive Routine Molecular Profiling of Leukemias in Routine Clinical Care
2017
·
Chi Young Ok
, Rajesh Singh
, et al.
·
Blood
·
16
Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase–negative anaplastic large cell lymphoma
2014
·
Meenakshi Mehrotra
, L. Jeffrey Medeiros
, et al.
·
Human Pathology
·
14
TET2 Mutations, Myelodysplastic Features, and a Distinct Immunoprofile Characterize Blastic Plasmacytoid Dendritic Cell Neoplasm in the Bone Marrow
2014
·
Khaled Alayed
, Keyur P. Patel
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
12
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India
2022
·
S Mangarule
, S Palkar
, et al.
·
Vaccine X
·
6
PDF
Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study
2022
·
S Mangarule
, S Prashanth
, et al.
·
Vaccine X
·
4
PDF
Zinc as adjunct treatment for clinical severe infection in young infants: A randomized double-blind placebo-controlled trial in India and Nepal
2025
·
Nitya Wadhwa
, Antara Sinha
, et al.
·
PLoS Medicine
·
1
PDF
New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia
2017
·
Talha Badar
, Rajyalakshmi Luthra
, et al.
·
Applied immunohistochemistry & molecular morphology
HER2 Assessment by MIP Microarray in a Breast Cancer Patient with Equivocal HER2 Status
2016
·
Hui Chen
, Alexis Bousamra
, et al.
·
Cancer Genetics
DNMT3A mutations exert a dominant adverse effect in De novo acute myeloid leukemia with concurrent FLT3 and NPM1 mutations
2015
·
Sanam Loghavi
, Zhuang Zuo
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Multigene Mutational Clinical Profiling Using Next Generation Sequencing in a Cohort of 451 Patients with MDS: Impact on Clinical Outcomes
2014
·
Keyur Patel
, Mark Routbort
, et al.
·
Blood
Chronic myelomonocytic leukemia: Next-generation sequencing in 30 treatment-naive cases.
2014
·
Priyanka Priyanka
, Ashita Sinha
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
16
Citation count:
330
H-index:
8
I10-index:
8
Year
Topic
Type